Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism

Journal of Virology

Volumn 79, Issue 9, 2005, Pages 5653-5664

  Maury, Wendy ^a   Thompson, Robert J ^a   Jones, Quentin ^a   Bradley, Sarahann ^b   Denke, Tara ^b,e   Baccam, Prasith ^c   Smazik, Matthew ^a   Oaks, J Lindsay ^d  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

^c Innovative Emergency Management Inc   (United States)

^d WASHINGTON STATE UNIVERSITY   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; NUCLEOTIDE; TRANSCRIPTION FACTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; ENHANCER REGION; EQUINE INFECTIOUS ANEMIA VIRUS; EVOLUTION; FIBROBLAST; GENETIC VARIABILITY; LENTIVIRINAE; LONG TERMINAL REPEAT; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS GENOME; VIRUS STRAIN; VIRUS TRANSCRIPTION; VIRUS VIRULENCE;

ADAPTATION, PHYSIOLOGICAL; AMINO ACID MOTIFS; ANIMALS; BASE SEQUENCE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENHANCER ELEMENTS (GENETICS); EQUINE INFECTIOUS ANEMIA; EVOLUTION; FIBROBLASTS; HORSES; INFECTIOUS ANEMIA VIRUS, EQUINE; MACROPHAGES; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; SERIAL PASSAGE; TERMINAL REPEAT SEQUENCES; VIRULENCE;

EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; LENTIVIRUS;

EID: 17444432992     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.9.5653-5664.2005     Document Type: Article

References (57)

1. Anderson, J. P., A. G. Rodrigo, G. H. Learn, Y. Wang, H. Weinstock, M. L. Kalish, K. E. Robbins, L. Hood, and J. I. Mullins. 2001. Substitution model of sequence evolution for the human immunodeficiency virus type 1 subtype B gp120 gene over the C2-V5 region. J. Mol. Evol. 53:55-62.
2. Baccam, P., R. J. Thompson, Y. Li, W. O. Sparks, M. Belshan, K. S. Dorman, Y. Wannemuehler, J. L. Oaks, J. L. Cornette, and S. Carpenter. 2003. Subpopulations of equine infectious anemia virus Rev coexist in vivo and differ in phenotype. J. Virol. 77:12122-12131.
3. Belshan, M., P. Baccam, J. L. Oaks, B. A. Sponseller, S. C. Murphy, J. Cornette, and S. Carpenter. 2001. Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony. Virology 279:185-200.
4. Belshan, M., M. E. Harris, A. E. Shoemaker, T. J. Hope, and S. Carpenter. 1998. Biological characterization of Rev variation in equine infectious anemia virus. J. Virol. 72:4421-4426.
5. Berkhout, B. 1999. HIV-1 evolution under pressure of protease inhibitors: climbing the stairs of viral fitness. J. Biomed. Sci. 6:298-305.
6. Carpenter, S., S. Alexandersen, M. J. Long, S. Perryman, and B. Chesebro. 1991. Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus. J. Virol. 65:1605-1610.
7. Carpenter, S., and B. Chesebro. 1989. Change in host cell tropism associated with in vitro replication of equine infectious anemia virus. J. Virol. 63:2492-2496.
8. Carvalho, M., and D. Derse. 1993. Physical and functional characterization of transcriptional control elements in the equine infectious anemia virus promoter. J. Virol. 67:2064-2074.
9. Carvalho, M., M. Kirkland, and D. Derse. 1993. Protein interactions with DNA elements in variant equine infectious anemia virus enhancers and their impact on transcriptional activity. J. Virol. 67:6586-6595.
10. Clapham, P. R., J. D. Reeves, G. Simmons, N. Dejucq, S. Hibbitts, and A. McKnight. 1999. HIV coreceptors, cell tropism and inhibition by chemokine receptor ligands. Mol. Membr. Biol. 16:49-55.
11. Cohen, J. 2003. HIV. Escape artist par excellence. Science 299:1505-1508.
12. Cook, R. F., C. Leroux, S. J. Cook, S. L. Berger, D. L. Lichtenstein, N. N. Ghabrial, R. C. Montelaro, and C. J. Issel. 1998. Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus. J. Virol. 72:1383-1393.
13. Derse, D., P. L. Dorn, L. Levy, R. M. Stephens, N. R. Rice, and J. W. Casey. 1987. Characterization of equine infectious anemia virus long terminal repeat. J. Virol. 61:743-747.
14. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
15. Goldman, N., and Yang, Z. 1994. A codon-based model of nucleotide substitution for protein-coding DNA sequences. Mol. Biol. Evol. 11:725-736.
16. Hall, T. A. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41:95-98.
17. Hines, R., B. R. Sorensen, M. A. Shea, and W. Maury. 2004. PU.1 binding to Ets motifs within the equine infectious anemia virus long terminal repeat (LTR) enhancer: regulation of LTR activity and virus replication in macrophages. J. Virol. 78:3407-3418.
18. Hoffman, T. L., and R. W. Doms. 1999. HIV-1 envelope determinants for cell tropism and chemokine receptor use. Mol. Membr. Biol. 16:57-65.
19. Kimura, M. 1983. The neutral theory of molecular evolution. Cambridge University Press, Cambridge, United Kingdom.
20. Klevjer-Anderson, P., W. P. Cheevers, and T. B. Crawford. 1979. Characterization of the infection of equine fibroblasts by equine infectious anemia virus. Arch. Virol. 60:279-289.
21. Kono, Y., and Y. Yokomizo. 1968. Attempts to cultivate the equine infectious anemia virus in various types of cells. Natl. Inst. Anim. Health Q. (Tokyo) 8:182-186.
22. Kuhner, M. K., J. Yamato, and J. Felsenstein. 1995. Estimating effective population size and mutation rate from sequence data using Metropolis-Hastings sampling. Genetics 140:1421-1430.
23. Kumar, S., K. Tamura, I. B. Jakobsen, and M. Nei. 2001. MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 17:1244-1245.
24. Learn, G. H., D. Muthui, S. J. Brodie, T. Zhu, K. Diem, J. I. Mullins, and L. Corey. 2002. Virus population homogenization following acute human immunodeficiency virus type 1 infection. J. Virol. 76:11953-11959.
25. Lichtenstein, D. L., J. K. Craigo, C. Leroux, K. E. Rushlow, R. F. Cook, S. J. Cook, C. J. Issel, and R. C. Montelaro. 1999. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo. Virology 263:408-417.
26. Liu, S. L., T. Schacker, L. Musey, D. Shriner, M. J. McElrath, L. Corey, and J. I. Mullins. 1997. Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses. J. Virol. 71:4284-4295.
27. Madden, C. R., and D. S. Shih. 1996. Analysis of the long terminal repeat from a cytopathic strain of equine infectious anemia virus. Virology 225:395-399.
28. Malmquist, W. A., D. Barnett, and C. S. Becvar. 1973. Production of equine infectious anemia antigen in a persistently infected cell line. Arch. Gesamte Virusforsch. 42:361-370.
29. Mansky, L. M. 1996. Forward mutation rate of human immunodeficiency virus type 1 in a T lymphoid cell line. AIDS Res. Hum. Retro-viruses 12:307-314.
30. Mansky, L. M. 2002. HIV mutagenesis and the evolution of antiretroviral drug resistance. Drug Resist. Updates 5:219-223.
31. Mansky, L. M., and H. M. Temin. 1995. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69:5087-5094.
32. Maury, W. 1994. Monocyte maturation controls expression of equine infectious anemia virus. J. Virol. 68:6270-6279.
33. Maury, W. 1998. Regulation of equine infectious anemia virus expression. J. Biomed. Sci. 5:11-23.
34. Maury, W., S. Bradley, B. Wright, and R. Hines. 2000. Cell specificity of the transcription-factor repertoire used by a lentivirus: motifs important for expression of equine infectious anemia virus in nonmonocytic cells. Virology 267:267-278.
35. Maury, W., J. L. Oaks, and S. Bradley. 1998. Equine endothelial cells support productive infection of equine infectious anemia virus. J. Virol. 72:9291-9297.
36. Maury, W., S. Ferryman, J. L. Oaks, B. K. Seid, T. Crawford, T. McGuire, and S. Carpenter. 1997. Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus. J. Virol. 71:4929-4937.
37. Maury, W., P. J. Wright, and S. Bradley. 2003. Characterization of a cytolytic strain of equine infectious anemia virus. J. Virol. 77:2385-2399.
38. Maury, W. J., S. Carpenter, K. Graves, and B. Chesebro. 1994. Cellular and viral specificity of equine infectious anemia virus Tat transactivation. Virology 200:632-642.
39. Oaks, J. L., T. C. McGuire, C. Ulibarri, and T. B. Crawford. 1998. Equine infectious anemia virus is found in tissue macrophages during subclinical infection. J. Virol. 72:7263-7269.
40. O'Rourke, K. I., L. E. Perryman, and T. C. McGuire. 1989. Cross-neutralizing and subclass characteristics of antibody from horses with equine infectious anemia virus. Vet. Immunol. Immunopathol. 23:41-49.
41. Orrego, A., C. J. Issel, R. C. Montelaro, and W. V. Adams, Jr. 1982. Virulence and in vitro growth of a cell-adapted strain of equine infectious anemia virus after serial passage in ponies. Am. J. Vet. Res. 43:1556-1560.
42. Overbaugh, J., and C. R. Bangham. 2001. Selection forces and constraints on retroviral sequence variation. Science 292:1106-1109.
43. Payne, S. L., K. La Celle, X. F. Pei, X. M. Qi, H. Shao, W. K. Steagall, S. Perry, and F. Fuller. 1999. Long terminal repeat sequences of equine infectious anaemia virus are a major determinant of cell tropism. J. Gen. Virol. 80(Pt. 3):755-759.
44. Payne, S. L., X. F. Pei, B. Jia, A. Fagerness, and F. J. Fuller. 2004. Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus. J. Virol. 78:2478-2485.
45. Payne, S. L., J. Rausch, K. Rushlow, R. C. Montelaro, C, Issel, M. Flaherty, S. Perry, D. Sellon, and F. Fuller. 1994. Characterization of infectious molecular clones of equine infectious anaemia virus. J. Gen. Virol. 75(Pt. 3):425-429.
46. Perry, S. T., M. T. Flaherty, M. J. Kelley, D. L. Clabough, S. R. Tronick, L. Coggins, L. Whetter, C. R. Lengel, and F. Fuller. 1992. The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro. J. Virol. 66:4085-4097.
47. Reis, J. K., J. K. Craigo, S. J. Cook, C. J. Issel, and R. C. Montelaro. 2003. Characterization of EIAV LTR variability and compartmentalization in various reservoir tissues of long-term inapparent carrier ponies. Virology 311: 169-180.
48. Rice, N. R., L. E. Henderson, R. C. Sowder, T. D. Copeland, S. Oroszlan, and J. F. Edwards. 1990. Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus. J. Virol. 64:3770-3778.
49. Rozas, J., and R. Rozas. 1999. DnaSP version 3: an integrated program for molecular population genetics and molecular evolution analysis. Bioinformatics 15:174-175.
50. Seo, T. K., J. L. Thorne, M. Hasegawa, and H. Kishino. 2002. Estimation of effective population size of HIV-1 within a host: a pseudomaximum-likelihood approach. Genetics 160:1283-1293.
51. Shankarappa, R., J. B. Margolick, S. J. Gange, A. G. Rodrigo, D. Upchurch, H. Farzadegan, P. Gupta, C. R. Rinaldo, G. H. Learn, X. He, X. L. Huang, and J. I. Mullins. 1999. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 73:10489-10502.
52. Simm, M., W. Chao, O. Pekarskaya, P. Sova, P. Gupta, R. Balachandran, and D. J. Volsky. 1996. Genetic variability and function of the long terminal repeat from syncytium-inducing and non-syncytium-inducing human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 12:801-809.
53. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
54. Verhoef, K., R. W. Sanders, V. Fontaine, S. Kitajima, and B. Berkhout. 1999. Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-κB enhancer element into a GABP binding site. J. Virol. 73:1331-1340.
55. Whetter, L., D. Archambault, S. Perry, A. Gazit, L. Coggins, A. Yaniv, D. Clabough, J. Dahlberg, F. Fuller, and S. Tronick. 1990. Equine infectious anemia virus derived from a molecular clone persistently infects horses. J. Virol. 64:5750-5756.
56. Zheng, Y. H., H. Sentsui, Y. Kono, and K. Ikuta. 2000. Mutations occurring during serial passage of Japanese equine infectious anemia virus in primary horse macrophages. Virus Res. 68:93-98.
57. Zheng, Y. H., H. Sentsui, M. Sugita, T. Nakaya, M. Kishi, K. Hagiwara, Y. Inoshima, C. Ishihara, Y. Kono, J. L. Lu, and K. Ikuta. 2000. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain. Virology 266:129-139.